Gene S. Cartwright Ph.D.
Net Worth

Last updated:

What is Gene S. Cartwright Ph.D. net worth?

The estimated net worth of Dr. Gene S. Cartwright Ph.D. is at least $162,623 as of 30 Jun 2015. He owns shares worth $30,623 as insider and has received compensation worth at least $132,000 in Guided Therapeutics, Inc..

What is the salary of Gene S. Cartwright Ph.D.?

Dr. Gene S. Cartwright Ph.D. salary is $12,000 per year as Chief Executive Officer, Pres, Acting Chief Financial Officer & Director in Guided Therapeutics, Inc..

How old is Gene S. Cartwright Ph.D.?

Dr. Gene S. Cartwright Ph.D. is 71 years old, born in 1954.

What stocks does Gene S. Cartwright Ph.D. currently own?

As insider, Dr. Gene S. Cartwright Ph.D. owns shares in one company:

Company Title Shares Price per share Total value
Guided Therapeutics, Inc. (GTHP) Chief Executive Officer, Pres, Acting Chief Financial Officer & Director 117,780 $0.26 $30,623

What does Guided Therapeutics, Inc. do?

Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.

Gene S. Cartwright Ph.D. insider trading

Guided Therapeutics, Inc.

Transaction Date Security Shares Price per share Total value Source
Purchase
Warrants 235,650 $0.1 $23,565
Purchase
Common Stock 37,504 $0.12 $4,500
Purchase
Common Stock 27,000 $0.49 $13,122
Purchase
Common Stock 23,000 $0.48 $11,086
Purchase
Common Stock 26,000 $0.49 $12,636
Purchase
Common Stock 24,000 $0.49 $11,712

Guided Therapeutics key executives

Guided Therapeutics, Inc. executives and other stock owners filed with the SEC: